These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 631639)

  • 21. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.
    Thomson AD; Cochrane MA; McFarlane IG; Eddleston AL; Williams R
    Nature; 1974 Dec; 252(5485):721-2. PubMed ID: 4437624
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocytotoxicity for oral epithelial cells in Behçet's disease: a case report.
    Reimer G; Djawari D
    Dermatologica; 1982 Feb; 164(2):82-9. PubMed ID: 6951776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lymphocytotoxicity test against isolated hepatocytes: study of the effector cells].
    Stefanini GF; Vomellini G; De Santis R; Ferrari F; Di Virgilio M
    Boll Soc Ital Biol Sper; 1977 Jul; 53(14):1199-205. PubMed ID: 603668
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.
    Dehoratius RJ; Henderson C; Strickland RG
    Clin Exp Immunol; 1976 Oct; 26(1):21-7. PubMed ID: 1087213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.
    Fernandez-Cruz E; Escartin P; Bootello A; Kreisler M; Segovia de Arana JM
    Clin Exp Immunol; 1978 Mar; 31(3):436-42. PubMed ID: 657588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.
    Sanchez-Tapias J; Thomas HC; Sherlock S
    Gut; 1977 Jun; 18(6):472-5. PubMed ID: 326639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphologic association of lymphocytes with hepatocytes in chronic liver disease.
    Kawanishi H
    Arch Pathol Lab Med; 1977 Jun; 101(6):286-90. PubMed ID: 577130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.
    Si L; Whiteside TL; Van Thiel DH; Rabin BS
    Lab Invest; 1984 Mar; 50(3):341-7. PubMed ID: 6366363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.
    Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R
    Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosette inhibition test in chronic liver disease.
    Salerno F; Fargion SR; Cappellini MD; Fiorelli G; Dioguardi N
    J Clin Pathol; 1976 Sep; 29(9):778-81. PubMed ID: 1086310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic aspects of liver disease.
    Kanagasundaram N; Leevy CM
    Med Clin North Am; 1979 May; 63(3):631-42. PubMed ID: 376975
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppressive effect of prednisolone on cytotoxicity of lymphocytes from normal persons against T24 cells.
    Nemoto R; Kato T
    Gan; 1979 Feb; 70(1):95-100. PubMed ID: 446979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.
    Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome.
    Rogers RS; Sams WM; Shorter RG
    Arch Dermatol; 1974 Mar; 109(3):361-3. PubMed ID: 4814937
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunology of liver disease.
    Triger DR
    Acta Med Port; 1981; (Suppl 2):21-33. PubMed ID: 6453499
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated cytotoxicity in chronic active liver disease: a new test system.
    Vogten AJ; Hadzic N; Shorter RG; Summerskill WH; Taylor WF
    Gastroenterology; 1978 May; 74(5 Pt 1):883-9. PubMed ID: 565311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.